Patents by Inventor Anders M. Naar

Anders M. Naar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods targeting miR-128 for regulating cholesterol/lipid metabolism
    Patent number: 9045749
    Abstract: Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: June 2, 2015
    Assignee: The General Hospital Corporation
    Inventors: Anders M. Naar, Seyed Hani Najafi-Shoushtari
  • Methods targeting miR-33 microRNAs for regulating lipid metabolism
    Patent number: 8859519
    Abstract: Compositions comprising nucleic acid sequences that target MiR-33a/b microRNAs are described, together with uses of the same in the treatment of certain disorders related to elevated serum triglyceride levels and obesity.
    Type: Grant
    Filed: August 25, 2011
    Date of Patent: October 14, 2014
    Assignee: The General Hospital Corporation
    Inventor: Anders M. Naar
  • METHODS TARGETING MIR-128 FOR REGULATING CHOLESTEROL/LIPID METABOLISM
    Publication number: 20140051746
    Abstract: Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.
    Type: Application
    Filed: January 13, 2012
    Publication date: February 20, 2014
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Anders M. Naar, Seyed Hani Najafi-Shoushtari
  • High throughput screens for small-molecule inhibitors of the nuclear receptor-like pathway regulating multidrug resistance in fungi
    Patent number: 8557746
    Abstract: The present invention relates to the identification of molecular mechanisms associated with multidrug resistance (MDR) in fungal infections. More specifically, fungi harbor a nuclear receptor-like pathway controlling MDR, which represents a novel therapeutic target for the treatment of MDR in pathogenic fungi such as C. glabrata.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: October 15, 2013
    Assignees: The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Anders M. Naar, Gerhard Wagner, Joy Nishikawa, Haribabu Arthanari
  • METHODS TARGETING MIR-33 MICRORNAS FOR REGULATING LIPID METABOLISM
    Publication number: 20130245093
    Abstract: Compositions comprising nucleic acid sequences that target MiR-33a/b microRNAs are described, together with uses of the same in the treatment of certain disorders related to elevated serum triglyceride levels and obesity.
    Type: Application
    Filed: August 25, 2011
    Publication date: September 19, 2013
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventor: Anders M. Naar
  • Regulation of MIR-33 MicroRNAs in the Treatment of Cholesterol-Related Disorders
    Publication number: 20120053229
    Abstract: Compositions comprising nucleic acid sequences that target MiR-33 microRNAs are described, together with uses of the same in the treatment of cholesterol-related disorders.
    Type: Application
    Filed: March 31, 2010
    Publication date: March 1, 2012
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventor: Anders M Naar
  • HIGH THROUGHPUT SCREENS FOR SMALL-MOLECULE INHIBITORS OF THE NUCLEAR RECEPTOR-LIKE PATHWAY REGULATING MULTIDRUG RESISTANCE IN FUNGI
    Publication number: 20100273676
    Abstract: The present invention relates to the identification of molecular mechanisms associated with multidrug resistance (MDR) in fungal infections. More specifically, fungi harbor a nuclear receptor-like pathway controlling MDR, which represents a novel therapeutic target for the treatment of MDR in pathogenic fungi such as C. glabrata.
    Type: Application
    Filed: March 31, 2010
    Publication date: October 28, 2010
    Applicants: THE GENERAL HOSPITAL CORPORATION, PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Anders M. Naar, Gerhard Wagner, Joy Nishikawa, Haribabu Arthanari